CSIMarket Company Name, Ticker, Competitors, else..
 
Prenetics Global Limited  (NASDAQ: PRE)
Other Ticker:  
 
 
Price: $3.8600 $-0.18 -4.455%
Day's High: $4.42 Week Perf: -10.23 %
Day's Low: $ 3.62 30 Day Perf: -27.44 %
Volume (M): 19 52 Wk High: $ 7.84
Volume (M$): $ 74 52 Wk Avg: $5.11
Open: $4.21 52 Wk Low: $2.85



 Market Capitalization (Millions $) 43
 Shares Outstanding (Millions) 11
 Employees 350
 Revenues (TTM) (Millions $) 22
 Net Income (TTM) (Millions $) -65
 Cash Flow (TTM) (Millions $) 147
 Capital Exp. (TTM) (Millions $) 0

Prenetics Global Limited
Prenetics Global Limited is a Hong Kong-based company that specializes in DNA testing and digital health solutions. Founded in 2014, Prenetics aims to empower individuals to take control of their health by providing personalized and preventive healthcare services. The company offers a range of DNA testing services, such as genetic wellness and predisposition testing, which help individuals understand their risk factors for certain health conditions. Prenetics also offers digital health solutions, including remote patient monitoring and telehealth services, to improve healthcare accessibility and efficiency. With a mission to enhance the quality of life for individuals globally, Prenetics has expanded its operations to several countries including Hong Kong, Singapore, Malaysia, Thailand, and the United Kingdom.


   Company Address: Unit 703-706, K11 Atelier King?s Road Quarry Bay 0
   Company Phone Number: 2210-9588   Stock Exchange / Ticker: NASDAQ PRE


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ILMN   -2.31%    
RVTY        0.36% 
CDNA   -3.54%    
FLGT        0.06% 
GH        2.5% 
ME   -69.86%    
• View Complete Report
   



Product Service News

Prenetics Launches IM8 in the U.S. with David Beckham, Redefining Personal Wellness

Published Tue, Jan 21 2025 8:06 PM UTC

In an era where health and wellness trends are constantly evolving, Prenetics is making a bold statement with its latest offering, the IM8, a comprehensive health solution making its debut in the United States. Co-founded by soccer legend and global icon David Beckham, the IM8 aims to revolutionize how consumers approach their foundational health.The exciting launch, held in...
Financing Agreement

Prenetics Secures Tencentns US$30 Million Investment in Insighta and Acquires Europa Sports Partners, Paving the Way for AI-Driven Cancer Detection and Expansion into Consumer Health Sector,

Published Tue, Oct 15 2024 12:30 PM UTC

Prenetics Global Limited Strengthens Its Portfolio with Tencentns Investment in Insighta and Acquisition of Europa Sports PartnersIn a notable development in the healthcare and wellness sectors, Prenetics Global Limited (NASDAQ: PRE), a leading health sciences company, has announced a strategic investment from technology giant Tencent and the acquisition of sports nutrition...
Merger and Acquisition

Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry

Published Mon, Aug 19 2024 12:30 PM UTC


In a significant move set to reshape the landscape of the sports nutrition market, Prenetics Global Limited (NASDAQ: PRE), a leading player in laboratory analytical instruments, has announced the acquisition of Europa Sports Partners. This partnership positions Prenetics to leverage Europa s vast distribution network of over 10,000 gyms across the United States, effecti...
Partnership

David Beckham Joins Prenetics to Co-Found New Health & Wellness Brand IM8

Published Thu, Jul 11 2024 12:30 PM UTC

Prenetics Partners with David Beckham to Launch New Health and Wellness Brand LOS ANGELES, July 11, 2024 Prenetics (NASDAQ: PRE), a prominent company in the health sciences sector, has announced a strategic partnership with former international footballer David Beckham. Beckham, who is also recognized for his entrepreneurial efforts and philanthropy, has become a strateg...
Contract

title Prenetics Shaping the Future of Genetics and Digital Health with Strong Financial Footing and Investor Confiden...

Published Mon, Jun 17 2024 12:30 PM UTC

Prenetics Sets Promising Path for Growth and Shareholder ValueIn a recent move to bolster investor relations and shareholder communications, Prenetics, a leading global genetics and digital health company, has tapped MZ Group as its strategic partner. As Prenetics gears up for future growth, this alliance aims to emphasize the company s impressive cash position, debt-free st...





  Prenetics Global Limited Outlook

On March 5 2025 the Prenetics Global Limited provided following guidance

nnPrenetics Global Limited Financial Performance and 2025 Outlooknn

Prenetics Global Limited has recently released its financial results for the fourth quarter and full year of 2024, showcasing impressive growth figures. In the fourth quarter, the company's revenue surged by an astonishing nn93.5%nn, reaching nn$10.5 millionnn. This remarkable performance continues to reflect a strong upward trajectory for the organization as it also reported a year-over-year revenue increase of nn40.9%nn, culminating in a total of nn$30.6 millionnn for the entire fiscal year of 2024.

While the company has announced these significant financial achievements, it has not specified detailed financial guidance f...





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com